Rezzayo (rezafungin) - FDA approval - candidemia and invasive candidiasis

The U.S. Food and Drug Administration (FDA) approved REZZAYO™ (rezafungin for injection) for the treatment of candidemia and invasive candidiasis in adults with limited or no alternative treatment options.

Full news here